NO20054562L - Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav - Google Patents

Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav

Info

Publication number
NO20054562L
NO20054562L NO20054562A NO20054562A NO20054562L NO 20054562 L NO20054562 L NO 20054562L NO 20054562 A NO20054562 A NO 20054562A NO 20054562 A NO20054562 A NO 20054562A NO 20054562 L NO20054562 L NO 20054562L
Authority
NO
Norway
Prior art keywords
solubility
impregnated powder
active ingredient
preparation
impregnated
Prior art date
Application number
NO20054562A
Other languages
English (en)
Other versions
NO20054562D0 (no
Inventor
Jerome Besse
Laurence Besse
Myriam Alphonse
Original Assignee
Sarl Galenix Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarl Galenix Innovations filed Critical Sarl Galenix Innovations
Publication of NO20054562D0 publication Critical patent/NO20054562D0/no
Publication of NO20054562L publication Critical patent/NO20054562L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2995—Silane, siloxane or silicone coating
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
    • Y10T428/2996—Glass particles or spheres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Det beskrives et impregnert pulver for å øke biotilgjengeligheten og/eller oppløseligheten for minst en aktiv bestanddel omfattende en fast, inert bærer i partikkelform, impregnert med et flytende medium omfattende en hydrofob fase og eventuelt en hydrofil fase, minst en surfaktant og minst en aktiv bestanddel oppløst i minst en av nevnte faser, der den eller de aktive bestanddeler også er til stede i minst en av fasene i form av en suspensjon. Et slikt impregnert pulver benyttes som en base for forskjellige preparater på det farmasøytiske, parafarmasøytiske og kosmetiske område, i næringskomplementområdet og i næringsprosessindustrien.
NO20054562A 2003-03-06 2005-10-04 Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav NO20054562L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302802A FR2851918B1 (fr) 2003-03-06 2003-03-06 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
PCT/FR2004/000541 WO2004080381A2 (fr) 2003-03-06 2004-03-05 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication

Publications (2)

Publication Number Publication Date
NO20054562D0 NO20054562D0 (no) 2005-10-04
NO20054562L true NO20054562L (no) 2005-12-01

Family

ID=32865308

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054562A NO20054562L (no) 2003-03-06 2005-10-04 Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav

Country Status (11)

Country Link
US (1) US7569274B2 (no)
EP (1) EP1603538A2 (no)
JP (1) JP4901469B2 (no)
AU (1) AU2004218859B2 (no)
BR (1) BRPI0408065A (no)
CA (1) CA2518200C (no)
FR (1) FR2851918B1 (no)
MX (1) MXPA05009440A (no)
NO (1) NO20054562L (no)
RU (1) RU2367412C2 (no)
WO (1) WO2004080381A2 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
JP2008531509A (ja) * 2005-02-25 2008-08-14 エフ．ホフマン−ラ ロシュ アーゲー 医薬品成分の改良された分散性を有する錠剤
US8663681B2 (en) 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US20080160097A1 (en) * 2006-12-28 2008-07-03 Avon Products, Inc. Method for imparting a cosmetic or therapeutic benefit to a topical surface and process for making
PL3150586T3 (pl) 2007-02-23 2020-06-01 Gilead Sciences, Inc. Modulatory farmakokinetycznych właściwości środków terapeutycznych
US20110097414A1 (en) * 2007-02-26 2011-04-28 Sandal Roshan Lal Pharmaceutical compositions comprising adsorbate of fenofibrate
WO2009012440A2 (en) * 2007-07-19 2009-01-22 Luzenac America, Inc. Silicone coatings, methods of making silicone coated articles and coated articles therefrom
US10531681B2 (en) 2008-04-25 2020-01-14 Sensient Colors Llc Heat-triggered colorants and methods of making and using the same
HRP20151357T1 (hr) 2008-05-02 2016-01-29 Gilead Sciences, Inc. Upotreba äśestica äśvrstog nosaäśa kako bi se poboljšala procesabilnost farmaceutskog agensa
US20090298952A1 (en) * 2008-05-07 2009-12-03 Brimmer Karen S Platable soluble dyes
US9113647B2 (en) 2008-08-29 2015-08-25 Sensient Colors Llc Flavored and edible colored waxes and methods for precision deposition on edible substrates
US20100102142A1 (en) * 2008-10-28 2010-04-29 Daria Tagliareni Scent dispenser assembly
RU2448684C2 (ru) * 2009-01-15 2012-04-27 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН "МНИИЭМ им. Г.Н. Габричевского" Роспотребнадзора) Препарат, содержащий биологически активные действующие вещества
KR100926952B1 (ko) 2009-06-04 2009-11-17 화인케미칼 주식회사 고분자 컴파운드용 오일함유 파우더
US11052029B2 (en) * 2009-06-16 2021-07-06 W. R. Grace & Co.-Conn. Cation compatible metal oxides and oral care compositions containing the metal oxides
MX344642B (es) 2009-12-29 2017-01-04 W R Grace & Co -Conn * Composiciones para formar peliculas que tienen un grado deseado de cobertura y metodos para hacer y usar las mismas.
US10987361B2 (en) 2010-02-08 2021-04-27 Shenzhen Evergreen Therapeutics Co., Ltd. Treating auto-immune and auto-inflammatory diseases
US10993879B2 (en) 2010-02-08 2021-05-04 Shenzhen Evergreen Therapeutics Co., Ltd. Pulmonary delivery of progestogen
EP3689364A1 (en) * 2010-02-08 2020-08-05 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer
WO2012027222A1 (en) 2010-08-24 2012-03-01 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
WO2013037650A1 (fr) * 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
JP2013169146A (ja) * 2012-02-17 2013-09-02 Kabaya Shokuhin Kk 新規清涼菓子およびその製造方法
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP2950923B1 (en) * 2013-02-01 2022-03-09 W.R. Grace & CO. - CONN. Porous silica gel as a carrier for liquid technologies
ES2763945T3 (es) 2013-02-06 2020-06-01 Hermes Arzneimittel Gmbh Composiciones farmacéuticas que incorporan fármacos en dosis bajas
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
PL3157506T3 (pl) 2014-06-20 2021-03-08 Hermes Arzneimittel Gmbh Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017081725A1 (ja) * 2015-11-09 2017-05-18 花王株式会社 口腔用組成物
CN105456203B (zh) * 2015-12-11 2018-05-15 中国人民解放军63975部队 一种药物-载体模式复合微粉制备方法
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102524880B1 (ko) * 2017-12-21 2023-04-21 한양대학교 산학협력단 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치
CN109123285A (zh) * 2018-08-27 2019-01-04 上海戚熊实业有限公司 一种太岁浸渍工艺制备的饮用水
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021126829A1 (en) 2019-12-16 2021-06-24 Rutgers, The State University Of New Jersey Continuous processes for manufacturing impregnated porous carriers and for manufacturing pharmaceuticals containing impregnated porous carriers
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2023214018A1 (en) 2022-05-06 2023-11-09 Galenix Innovations Gastro-retentive swellable sustained release composition
KR102726949B1 (ko) * 2023-12-22 2024-11-06 대가파우더시스템 주식회사 유연성 고체형 지혈제 조성물, 유연성 고체형 지혈제 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468815A (en) * 1973-10-18 1977-03-30 Vymatt Sa Pharmaceutical compositions
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
IT1291362B1 (it) * 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
JP2000026283A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した粉末組成物
EP2127642A3 (en) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
WO2002083102A1 (en) * 2001-02-23 2002-10-24 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
ITMI20011756A1 (it) * 2001-08-09 2003-02-09 Remedia S R L Composizione farmaceutica comprendente una microemulsione doppia acqua/olio/acqua incorporata in un supporto solido
ITMI20012694A1 (it) * 2001-12-19 2003-06-19 Remedia S R L Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido

Also Published As

Publication number Publication date
WO2004080381A2 (fr) 2004-09-23
AU2004218859A1 (en) 2004-09-23
WO2004080381A3 (fr) 2005-07-28
JP4901469B2 (ja) 2012-03-21
RU2367412C2 (ru) 2009-09-20
CA2518200A1 (fr) 2004-09-23
FR2851918A1 (fr) 2004-09-10
US20060182691A1 (en) 2006-08-17
JP2006519820A (ja) 2006-08-31
EP1603538A2 (fr) 2005-12-14
FR2851918B1 (fr) 2006-06-16
NO20054562D0 (no) 2005-10-04
CA2518200C (fr) 2013-04-30
AU2004218859B2 (en) 2009-10-15
BRPI0408065A (pt) 2006-02-14
US7569274B2 (en) 2009-08-04
RU2005130989A (ru) 2006-08-10
MXPA05009440A (es) 2006-04-07

Similar Documents

Publication Publication Date Title
NO20054562L (no) Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav
PT787011E (pt) Pré-concentrado de microemulsão compreendendo um macrólido
AR036852A1 (es) Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
DE69824632D1 (de) Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
PT969856E (pt) Sistemas binarios hidr¿filos para administracao de ciclosporina
WO2003040144A3 (en) Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
UA40634C2 (uk) Мікрокапсула, яка містить суспензію твердої біологічно активної сполуки, і спосіб її одержання
DE69942205D1 (de) Microemulsionen als feste dosisformen zur oralen verabreichung
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
JP5906194B2 (ja) 皮膚外用剤
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
EA200400765A1 (ru) Фармацевтические составы, содержащие соединения активного витамина d
EP1681046A3 (de) Kosmetische, pharmazeutische und dermatologische Zubereitungen enthaltend Copolymerwachse
DE50000639D1 (de) Verfahren zur stabilisierung von polyvinylpyrrolidon-zubereitungen
IT1270239B (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
DE60017361D1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
KR940021054A (ko) 캡슐형 유비데카레논 경구 제제
NL7612796A (nl) Werkwijze voor het bereiden van nieuwe benziso- thiazolonderivaten, werkwijze voor het remmen van bloedplaatjesaggregatie in vitro, alsmede deze verbindingen als werkzaam bestanddeel be- vattende, farmaceutische preparaten.
DE60308899D1 (de) Quaternäre verbindungen enthaltend propolis als wirkstoff
WO2001007015A3 (de) Schnellfreisetzende extrudate und verfahren zu ihrer herstellung sowie daraus erhältliche zubereitungen
AU2002214223A1 (en) Long-acting cytokine derivatives and pharmaceutical compositions comprising them
ATE136783T1 (de) Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n- methylpiperidino)-ethyl>-phosphat und verfahren zu dessen herstellung
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application